Navigation Links
Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings

HASBROUCK HEIGHTS, NJ (June 21, 2007) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced that detailed results from the Company’s recently completed studies of NX-1207 for benign prostatic hyperplasia (BPH) will be presented at a series of upcoming U.S. urology meetings, beginning in September at the South Central American Urological Association Meeting in Colorado Springs. These independent podium presentations will be given by leading clinical research urologist principal investigators from the clinical trials. Further specific details on the upcoming presentations will be announced at a later date.

The Company has completed a series of studies of the safety and efficacy of NX-1207 for BPH, including two Phase 1-2 studies and a Phase 2 study as well as several follow-up studies of patients for up to 3 ½ years after NX-1207 treatment. The Company’s recently completed prospective randomized placebo controlled Phase 2 U.S. study confirmed the positive efficacy and safety results for NX-1207 from earlier studies. After 3 months, patients treated with NX-1207 had a mean improvement of 9.35 points in AUA Symptom Score values, the standard scale used to evaluate BPH drugs and treatments. This improvement was significantly greater than the 3.5 to 5 points typically reported for currently approved drugs for BPH. The results of the trial demonstrated the excellent safety and side effect profile of NX-1207. In particular, patients given NX-1207 had no (0%) significant sexual side effects. Follow-up studies have provided data showing that NX-1207 can provide enduring benefits of up to 42 months or more following treatment.

The AUA Symptom Score is a standardized and widely accepted questionnaire used to assess the severity of BPH symptoms and the efficacy of treatments for BPH. The AUA Score consists of seven questions relating to frequency of problems with urination such a
'"/>




Page: 1 2 3

Related medicine technology :

1. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
2. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
3. Nymox Reports Completion of New 42 Month Follow-up Study of NX-1207 for BPH
4. Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nymox Announces Data Presented Upcoming Urology Meetings
(Date:2/26/2015)... Feb. 26, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... manufacturer of the t:slim® and t:flex™ Insulin Pumps, today ... 5,250,000 shares of its common stock at a price ... proceeds to Tandem from this offering are expected to ... and other estimated offering expenses payable by Tandem. All ...
(Date:2/26/2015)... MOUNTAIN VIEW, Calif. , Feb. 26, 2015  IRIDEX ... will release its fourth quarter and full year 2014 financial ... 2015.   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, March 5, ... other business developments. Interested parties may access the ...
(Date:2/26/2015)... -- Legislation passed today by the House Ways and ... inappropriate prescriptions in Medicare Part D from crossing the ... Act (PIMA) of 2014 , introduced by Ways and ... and Ranking Member Jim McDermott (D-WA), recognizes the need ... the right policies, said the Pharmaceutical Care Management Association ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2
... on efforts to enhance the,clinical research enterprise, ... of,Clinical Research Organizations (ACRO), which represents the ... the public in the U.S. and worldwide, ... formed Clinical Trial Transformation,Initiative (CTTI). The goal ...
... for the Treatment of Fever ... Achieves Primary Endpoint ... SAN DIEGO, May 6 Cadence Pharmaceuticals,Inc. (Nasdaq: ... proprietary product candidates principally,for use in the hospital setting, today ...
Cached Medicine Technology:Association of Clinical Research Organizations (ACRO) to Help Lead Clinical Trials Transformation Initiative 2Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 2Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 3Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 4Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 5Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 6Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 7Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 8Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 9
(Date:2/28/2015)... (PRWEB) February 28, 2015 The noted ... announce that they have officially relaunched their website. The ... user-friendly, but it contains a new section about their ... to read the full biographies of each Friedman Dental ... of the website was designed to provide our patients ...
(Date:2/28/2015)... Developers of FCPX plugins and ... plugin for Final Cut Pro X entitled FCPX Overlay Chromatic ... gives users total control over 6k lens dirt overlays inside ... Film Studios. “FCPX Overlay Chromatic was professionally designed to add ... , FCPX Overlay Chromatic Grunge 6K is a resourceful tool ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 “ Powermod ” ... Report, which takes a look at the latest and coolest ... special reporter for NewsWatch and a technology expert, conducted the ... variety of charging solutions. , Getting stuck with a low ... is a problem that people face on a daily basis. ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Memphis, TN: ... 5, 2015, for a new security reader named ... The reader is a new biometric scanner that ... with new features, the new biometric scanner provides ... and administrators. , MedixSafe narcotics lockers ...
(Date:2/28/2015)... My Shiney Hiney® LLC., the renowned brand in ... Vegas, Nevada for the annual ASD Market Week tradeshow. ... consumer-goods tradeshows and My Shiney Hiney will be one of ... Hiney can be found at booth number C1663. , My ... personal hygiene brush and cleansing system exclusively created to clean ...
Breaking Medicine News(10 mins):Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2
... Adoption Across 40 Specialties in Prominent Academic ... for charge capture technologies, today announced that ... successfully implemented Professional Intelligent Charge Capture for ... this first phase of KMSF,s staggered deployment ...
... announced that the 4th Annual Stem Cell Summit, ... scientists and investors, will focus on commercialization of ... one-day event where attendees explore the therapeutic applications ... path to stem cell product commercialization, and the ...
... and unparalleled level of service to guests LAS VEGAS, Jan. ... the newest resort destination on South Las Vegas Boulevard set ... add an on-property pharmacy to its list of amenities. Located ... advantage of a full-service pharmacy, open 365 days a year ...
... Jan. 7 Ingenuity Systems, the,leading provider of ... release of IPA 7 with contextual data analysis. ... of powerful biological filters and other,tools that make ... fine-,tune scientific hypotheses in relation to a particular ...
... Jan. 7 DTC Perspectives Inc., the leading DTC ... DTC National conference and DTC Perspectives Magazine , ... Division. OTC Perspectives will serve the unmet needs of ... publications all designed to focus on the myriad of ...
... January 7 Misys plc (LSE: MSY), the,global ... Farmers Bank has chosen Misys to strengthen its ... and service its customers throughout,the country. , ... rural bank that provides retail banking,services in the ...
Cached Medicine News:Health News:Kentucky Medical Services Foundation Completes Successful Charge Capture Technology Conversion 2Health News:Kentucky Medical Services Foundation Completes Successful Charge Capture Technology Conversion 3Health News:Stem Cell Product Commercialization Focus of Summit 2Health News:M Resort, Spa and Casino to Include On-Property Pharmacy 2Health News:IPA 7 Introduces Unique Contextual Search and Analysis Capabilities 2Health News:Crucial OTC Marketing Issues to be Addressed by New OTC Perspectives Division of DTC Perspectives, Inc. 2Health News:Philippine Farmers Bank Turns to Misys to Underpin its Consumer Lending Business 2Health News:Philippine Farmers Bank Turns to Misys to Underpin its Consumer Lending Business 3
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
... Scrub swabsticks is formulated with ... to prevent dryness. It contains ... to 0.75% available iodine. Povidone-Iodine ... surface pathogens, including gram-negative and ...
Medicine Products: